DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)" report to their offering.
Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020), provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc.
The report provides a regional analysis of the allergy immunotherapy market, including the following regions: the US, Europe and Rest of the World. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Allergy refers to a condition in which the immune system abnormally reacts to the foreign substance. The foreign substance could be in the form of particular food, pollen, pets, metals, fur, dust, etc. to which the body becomes hypersensitive when comes into contact. The foreign substance that triggers the hypersensitive response in the body is known as an allergen. Generally, most substances that cause allergies are normally harmless to the human body and have no effect on the vast majority of people that are not allergic. Allergy is not a disease, it is a mere over-reaction of body to the foreign substance that is not harmful. To diagnose an allergy skin test, blood test and allergy component tests are undertaken. Allergies are generally seasonal and perennial in nature.
The global allergy immunotherapy market has increased at a significant CAGR during the years 2009-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The allergy immunotherapy market is expected to increase due to growth in healthcare expenditure, rising incidence of chronic diseases and increasing global pollution, etc. Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc.
The key players of the allergy immunotherapy market ALK-Abello, Allergy Therapeutics, Merck Group and Stallergenes, who are also profiled with their financial information and respective business strategies.
- Allergy Therapeutics plc
- Merck Group
Key Topics Covered:
1. Executive Summary
3. Global Market Analysis
4. Regional Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/khp5ht/global_allergy